Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Therapy for glioblastoma: is it working?

Zanders ED, Svensson F, Bailey DS.

Drug Discov Today. 2019 May;24(5):1193-1201. doi: 10.1016/j.drudis.2019.03.008. Epub 2019 Mar 13. Review.

3.

Comparison of glioblastoma (GBM) molecular classification methods.

Lee E, Yong RL, Paddison P, Zhu J.

Semin Cancer Biol. 2018 Dec;53:201-211. doi: 10.1016/j.semcancer.2018.07.006. Epub 2018 Jul 19. Review.

PMID:
30031763
4.

Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.

Lee HW, Lee K, Kim DG, Yang H, Nam DH.

Histol Histopathol. 2016 Mar;31(3):269-83. doi: 10.14670/HH-11-695. Epub 2015 Nov 18. Review.

PMID:
26578300
5.

Recent advances and future of immunotherapy for glioblastoma.

Kamran N, Calinescu A, Candolfi M, Chandran M, Mineharu Y, Asad AS, Koschmann C, Nunez FJ, Lowenstein PR, Castro MG.

Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Review.

6.

Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.

Romaguera-Ros M, Peris-Celda M, Oliver-De La Cruz J, Carrión-Navarro J, Pérez-García A, García-Verdugo JM, Ayuso-Sacido A.

Stem Cell Rev. 2012 Mar;8(1):288-98. doi: 10.1007/s12015-011-9283-1. Review.

PMID:
21717133
7.

Immunotherapy and Epigenetic Pathway Modulation in Glioblastoma Multiforme.

Chin C, Lunking ES, de la Fuente M, Ayad NG.

Front Oncol. 2018 Nov 13;8:521. doi: 10.3389/fonc.2018.00521. eCollection 2018. Review.

8.

Current trends in targeted therapies for glioblastoma multiforme.

Ohka F, Natsume A, Wakabayashi T.

Neurol Res Int. 2012;2012:878425. doi: 10.1155/2012/878425. Epub 2012 Mar 5.

9.

Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.

Cai X, Sughrue ME.

Oncotarget. 2017 Dec 20;9(10):9540-9554. doi: 10.18632/oncotarget.23476. eCollection 2018 Feb 6. Review.

10.

Advances in immunotherapy for the treatment of glioblastoma.

Tivnan A, Heilinger T, Lavelle EC, Prehn JH.

J Neurooncol. 2017 Jan;131(1):1-9. doi: 10.1007/s11060-016-2299-2. Epub 2016 Oct 14. Review.

11.

Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.

Song WS, Yang YP, Huang CS, Lu KH, Liu WH, Wu WW, Lee YY, Lo WL, Lee SD, Chen YW, Huang PI, Chen MT.

J Chin Med Assoc. 2016 Oct;79(10):538-45. doi: 10.1016/j.jcma.2016.03.010. Epub 2016 Aug 13.

12.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

13.

Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Kroeger KM, Muhammad AK, Baker GJ, Assi H, Wibowo MK, Xiong W, Yagiz K, Candolfi M, Lowenstein PR, Castro MG.

Discov Med. 2010 Oct;10(53):293-304. Review.

14.

Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.

Perrin SL, Samuel MS, Koszyca B, Brown MP, Ebert LM, Oksdath M, Gomez GA.

Biochem Soc Trans. 2019 Apr 30;47(2):625-638. doi: 10.1042/BST20180444. Epub 2019 Mar 22. Review.

PMID:
30902924
15.

Glioblastoma multiforme: State of the art and future therapeutics.

Wilson TA, Karajannis MA, Harter DH.

Surg Neurol Int. 2014 May 8;5:64. doi: 10.4103/2152-7806.132138. eCollection 2014. Review.

16.

Emerging patents in the therapeutic areas of glioma and glioblastoma.

Harris M, Svensson F, Kopanitsa L, Ladds G, Bailey D.

Expert Opin Ther Pat. 2018 Jul;28(7):573-590. doi: 10.1080/13543776.2018.1494155. Epub 2018 Jul 9. Review.

PMID:
29950117
17.

Dendritic cell vaccines for high-grade gliomas.

Eagles ME, Nassiri F, Badhiwala JH, Suppiah S, Almenawer SA, Zadeh G, Aldape KD.

Ther Clin Risk Manag. 2018 Jul 26;14:1299-1313. doi: 10.2147/TCRM.S135865. eCollection 2018. Review.

18.

Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.

Miranda A, Blanco-Prieto M, Sousa J, Pais A, Vitorino C.

Int J Pharm. 2017 Oct 5;531(1):372-388. doi: 10.1016/j.ijpharm.2017.07.056. Epub 2017 Jul 27. Review.

PMID:
28755993
19.

Emerging treatment strategies for glioblastoma multiforme.

Carlsson SK, Brothers SP, Wahlestedt C.

EMBO Mol Med. 2014 Nov;6(11):1359-70. doi: 10.15252/emmm.201302627. Review.

20.

Promising vaccines for treating glioblastoma.

Swartz AM, Shen SH, Salgado MA, Congdon KL, Sanchez-Perez L.

Expert Opin Biol Ther. 2018 Nov;18(11):1159-1170. doi: 10.1080/14712598.2018.1531846. Epub 2018 Oct 15. Review.

PMID:
30281978

Supplemental Content

Support Center